Suchergebnisse

1. Sane J, Schmidt T, Isla N, Ibrahim R, Boshevska G, Mayigane LN, Perriat D, Stauke J, Esquevin S, Fehr A et al. (2023): Key lessons learnt from COVID-19 intra-action reviews in the Republic of Moldova, Montenegro, Kosovo and North Macedonia 2020–2021: a qualitative study.
   BMJ Open 13 (3): e066279. doi: 10.1136/bmjopen-2022-066279. mehr

2. Boklage E, Weiss B, Hanefeld J, et al (2023): Telemedicine in emergency responses: reflections from a critical care telemedicine programme between Uzbekistani and German clinicians during COVID-19.
   BMJ Health & Care Informatics 30 (1): 3. doi: 10.1136/bmjhci-2022-100675. mehr

3. Antonia P, Sarah R, Catherine LJO, Helen B, Magdalena B, Pauline C, Deepa G, Louise H, Benjamin K, Wiebe K, Carole L, Melanie M, Rudzani M, Dawid P, James T, Matthew CT, Zane Y, Ole W, Thomas H (2023): Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel.
   Vaccine: 11. doi: 10.1016/j.vaccine.2023.02.027. mehr

4. Robert Koch-Institut (2023): RKI-Ratgeber Mpox/Affenpocken.
   Epid Bull (1): 3-12. doi: 10.25646/10943. mehr

5. Schönfeld V, Heininger U, Littmann M, Steinmetz I, Matysiak-Klose D (2023): Aktuelle Epidemiologie von Bordetella parapertussis-Infektionen in Deutschland.
   Epid Bull. (33): 3-14. doi: 10.25646/11681. mehr

6. Sprengholz P, Bruckmann R, Wiedermann M, Brockmann D, Betsch C (2023): From delta to omicron: The role of individual factors and social context in self-reported compliance with pandemic regulations and recommendations.
   Social Science & Medicine 317: 115633. doi: 10.1016/j.socscimed.2022.115633. mehr

7. Mock F, Schöll M, an der Heiden M, Rexroth U (2023): Erfahrungen der lokalen Gesundheitsbehörden in Deutschland mit dem Krisenmanagement während der COVID-19-Pandemie in den Jahren 2020 – 2022.
   Epid Bull. (32): 3-9. doi:10.25646/11673. mehr

8. Junker S, Damerow S, Walther L, Mauz E (2023): Development of a prototype for high-frequency mental health surveillance in Germany: data infrastructure and statistical methods.
   Front Public Health. (11): 1208515. doi: 10.3389/fpubh.2023.1208515. mehr

9. Said D, Abu Sin M, Zanuzdana A, Schweickert B, Eckmanns T (2023): Alten- und Pflegeheime – die COVID-19-Pandemie als Mahnung: Infektionshygienische Maßnahmen und Einflussfaktoren auf die Gesundheit der Bewohnenden. [Long-term care facilities—the COVID-19 pandemic as an urgent call: infection prevention, control measures, and factors influencing the health of residents.]
   Bundesgesundheitsbl 66 (2): 248–255. doi: 10.1007/s00103-023-03657-9. mehr

10. Henze L, Braun J, Meyer-Arndt L, Jürchott K, Schlotz M, Michel J, Grossegesse M, Mangold M, Dingeldey M, Kruse B, Holenya P, Mages N, Reimer U, Eckey M, Schnatbaum K, Wenschuh H, Timmermann B, Klein F, Nitsche A, Giesecke-Thiel C, Loyal L, Thiel A (2023): Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.
    Front Immunol. 14: 1056525. Epub 2023 Jan 31. doi: 10.3389/fimmu.2023.1056525. mehr

11. Pozo-Martin F, Beltran Sanchez MA, Müller SA, Diaconu V, Weil K, El Bcheraoui C (2023): Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review.
    Eur J Epidemiol.: 1-24. doi: 10.1007/s10654-023-00963-z. mehr

12. Nübel J, Du Y, Baumert J, Hapke U, Färber F, Heidemann C, Scheidt-Nave C (2023): Perceived Chronic Stress Is Associated With the German Diabetes Risk Score Among Adults Without Known Diabetes in Germany.
    Psychosomatic Medicine 85 (4): 8. doi: 10.1097/PSY.0000000000001183. mehr

13. SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration (for RKIDu Y, Heidemann C, Scheidt-Nave C) (2023): SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    European Heart Journal 44 (28): 14. doi: 10.1093/eurheartj/ehad260. mehr

14. NCD Risk Factor Collaboration (NCD-RisC) (for RKI Du Y, Heidemann Christin, Scheidt-Nave Christa) (2023): Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c.
    Nature Medicine 2023 (29): 33. doi: 10.1038/s41591-023-02610-2. mehr

15. Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors) (2023): Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
    Euro Surveill. 2023 28 (47): doi: 10.2807/1560-7917.ES.2023.28.47.2300186. mehr

16. Ständige Impfkommission, Deutsche Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e.V., Kling K, Külper-Schiek, Rothe C, Alberer M, Boecken G, Bogdan C, Feldt T, Köhler C, Ledig T, Löscher T, Meerpohl J, Mertens T, Ramharter M, Rieke B, Röbl-Mathieu M, Rosenbusch D, Schmidt-Chanasit J, Wichmann O, Wiedermann U, Zepp F, Burchard G (AG-Sprecher) (2023): Empfehlungen der Ständigen Impfkommission (STIKO) und der Deutschen Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit e.V. (DTG) zu Reiseimpfungen.
    Epid Bull (14): 1-194. doi: 10.25646/11201.2. mehr

17. Offergeld R, Preußel K, Zeiler T, Aurich K, Baretti BI, Ciesek S, Corman VM, Dienst V, Drosten C, Görg S, Greinacher A, Grossegesse M, Haller S, Heuft H-G, Hofmann N, Horn PA, Houareau C, Gülec I, Klingberg CLJ, Juhl D, Lindemann M, Martin S, , Neuhauser HK, Nitsche A, Ohme J, Pleine S, Sachs UJ, Schaade L, Schäfer R, Scheiblauer H, Schlaud M, Schmidt M, Umhau M, Vollmer T, Wagner FF, Wieler LH, Wilking H, Ziemann M, Zimmermann M, an der Heiden M (2023): Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022.
    Pathogens (12): 551. doi: 10.3390/pathogens12040551. mehr

18. Robert Koch-Institut (RKI) (2023): FSME: Risikogebiete in Deutschland (Stand: Januar 2023)
    Epid Bull (9): 3-22. doi: 10.25646/11176. mehr

19. Maier BF, Burdinski A, Wiedermann M, Rose AH, Schlosser F, An der Heiden M, Wichmann O, Harder T, Brockmann D (2023): Modeling the impact of the Omicron infection wave in Germany.
    Biol Methods Protoc. 8 (1): bpad005. doi: 10.1093/biomethods/bpad005. mehr

20. Walde J, Chaturvedi M, Berger T, Bartz A, Killewald R, Tomori DV, Rübsamen N, Lange B, Scholz S, Treskova M, Bucksch K, Jarvis CI, Mikolajczyk R, Karch A, Jaeger VK (2023): Effect of risk status for severe COVID-19 on individual contact behaviour during the SARS-CoV-2 pandemic in 2020/2021—an analysis based on the German COVIMOD study.
    BMC Infect Dis. 23 (1): 205. doi: 10.1186/s12879-023-08175-2. mehr

Resultate 101 bis 120 von insgesamt 12.037